COMMUNIQUÉS West-GlobeNewswire

Nabriva Therapeutics Appoints Jennifer Schranz, M.D., as Chief Medical Officer
21/03/2018
DUBLIN, Ireland and KING OF PRUSSIA, Pa., March 21, 2018 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV ), a clinical stage biopharmaceutical company engaged in the research and development of novel anti- [...]
Capricor Therapeutics to Present at Upcoming Oppenheimer and Needham Healthcare Conferences
21/03/2018
LOS ANGELES, March 21, 2018 (GLOBE NEWSWIRE) -- Capricor Therapeutics (NASDAQ: CAPR ) today announced that it will participate in two upcoming investment banking conferences, Oppenheimer’s 28 th Annual Healthcare [...]
Recro Pharma to Present at the 17th Annual Needham Healthcare Conference
21/03/2018
MALVERN, Pa., March 21, 2018 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (Nasdaq: REPH ), a revenue generating specialty pharmaceutical company focused on therapeutics for hospital and other acute care settings, today [...]
Akari Therapeutics Announces Fourth Quarter and Full Year 2017 Financial Results and Highlights Recent Clinical Progress
21/03/2018
Received Regulatory Clearance in Europe to Open First Clinical Trial Site for Phase III PNH Naïve Trial CAPSTONE, the Phase III Naïve PNH Trial Expected to Open in Q1 2018 Phase II PNH Trial Completed With Primary [...]
Fennec Pharmaceuticals Receives Fast Track Designation by FDA for PEDMARK
21/03/2018
RESEARCH TRIANGLE PARK, N.C., March 21, 2018 (GLOBE NEWSWIRE) -- Fennec Pharmaceuticals Inc. (NASDAQ: FENC ) (TSX: FRX ), a specialty pharmaceutical company, today announced that the U.S. Food and Drug Administration ( [...]
EDAP TMS SA : EDAP Announces CIGNA as First Major U.S. Private Health Insurer to Cover HIFU for Prostate Procedure
21/03/2018
Insurer Takes its Cue from Updated NCCN Guidelines, Which Recognizes HIFU as Salvage Treatment for Prostate Cancer Lyon, France, Austin, TX -- March 21, 2018 - EDAP TMS SA (Nasdaq: EDAP) today announced that CIGNA [...]
Amphastar Announces Final Judgment in the Patent Litigation against Momenta Pharmaceuticals, Inc. and Sandoz Inc.
21/03/2018
RANCHO CUCAMONGA, Calif., March 21, 2018 (GLOBE NEWSWIRE) -- Amphastar Pharmaceuticals, Inc. (NASDAQ: AMPH ) announced that on March 20, 2018, the United States Court for the District of Massachusetts (the “District [...]
PotNetwork Holding Inc. Leadership Appears on The Mick Bazsuly Show, Projects 60-70% Gains in Revenues for 2018
21/03/2018
FORT LAUDERDALE, Fla., March 21, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- PotNetwork Holding Inc. (OTC Pink:POTN) On Tuesday the 20th of March in 2018, PotNetwork Holding Inc. CEO Dr. Richard Goulding and Senior [...]
RavenQuest Obtains OTCQB Listing Under Symbol “RVVQF”
21/03/2018
VANCOUVER, British Columbia, March 21, 2018 (GLOBE NEWSWIRE) -- RavenQuest BioMed Inc. (the “Company” or “RavenQuest”) – (CSE:RQB) (OTCQB:RVVQF) (Frankfurt: 1IT ) is pleased to announce that OTC Markets Group Inc. has [...]
Amarin Announces First Middle East Approval for Vascepa®
21/03/2018
BEDMINSTER, N.J. and DUBLIN, Ireland, March 21, 2018 (GLOBE NEWSWIRE) -- Amarin Corporation plc (NASDAQ: AMRN ), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve [...]
Helsinn Group announces agreement to acquire worldwide rights to Valchlor/Ledaga, an approved and marketed alkylating agent for topical treatment of mycosis fungoides type cutaneous T-cell lymphoma
21/03/2018
Helsinn Group announces agreement to acquire worldwide rights to Valchlor ® /Ledaga ® - an approved and marketed alkylating agent for the topical treatment of mycosis fungoides- type cutaneous T- cell lymphoma, a rare [...]
Notice Convening the Annual General Meeting
21/03/2018
March 21, 2018 Announcement no. 6 Notice Convening the Annual General Meeting The Board of Directors hereby convenes the Annual General Meeting of BioPorto A/S: April 13, 2018, at 3.00 pm (CET), At the Company’s address [...]
Veritas Pharma Completes the 100% Takeover of Cannevert Therapeutics
21/03/2018
VANCOUVER, British Columbia, March 21, 2018 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt: 2VP ) ( “ Veritas ” or the “Company”) is pleased to announce the Company has completed the 100% [...]
DBV Technologies Announces Pricing of $150.0 million (€122.5 million) Global Offering of Ordinary Shares, Including in the Form of American Depositary Shares
21/03/2018
Montrouge, France, March 21, 2018 DBV Technologies Announces Pricing of $150.0 million ( € 122.5 million) Global Offering of Ordinary Shares, Including in the Form of American Depositary Shares DBV Technologies (the " [...]
DBV Technologies annonce le prix de son offre globale d'actions ordinaires, pouvant prendre la forme d'American Depositary Shares, pour un montant total de 150 millions de dollars américains
21/03/2018
Montrouge, France, 21 Mars 2018, 8h00 CET DBV Technologies annonce le prix de son offre globale d'actions ordinaires, pouvant prendre la forme d'American Depositary Shares, pour un montant total de 150 millions de [...]
Financière de Tubize SA: Convening of the ordinary and extraordinary general meetings of shareholders of the 25th of April 2018
21/03/2018
Financière de Tubize SA/NV Allée de la Recherche 60 1070 Brussels BE 0403.216.429 www.financiere-tubize.be CONVENING OF THE ORDINARY AND EXTRAORDINARY GENERAL MEETINGS OF SHAREHOLDERS OF 25 APRIL 2018 The shareholders [...]
Financière de Tubize SA: Convocation de l'assemblée générale ordinaire et de l'assemblée générale extraordinaire des actionnaires du 25 avril 2018
21/03/2018
Financière de Tubize SA Allée de la Recherche 60 1070 Bruxelles BE 0403.216.429 www.financiere-tubize.be CONVOCATION DE L'ASSEMBLEE GENERALE ORDINAIRE DES ACTIONNAIRES ET DE L'ASSEMBLEE GENERALE EXTRAORDINAIRE DU 25 [...]
MHRA Grants UK Patients Early Access to Akcea Therapeutics’ Volanesorsen for Familial Chylomicronaemia Syndrome (FCS)
21/03/2018
LONDON, March 21, 2018 (GLOBE NEWSWIRE) -- Akcea Therapeutics United Kingdom (UK) Ltd today announced that volanesorsen has been granted a positive scientific opinion through the Early Access to Medicines Scheme (EAMS) [...]
PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")
21/03/2018
REGULATED INFORMATION GHENT, Belgium, 21 March 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major [...]

Pages